RCE Technologies
Carlsbad, US · Founded 2018 · 1 known investors
RCE Technologies develops a wrist-worn wearable (Infrasensor) that uses infrared sensors and machine learning to detect signals associated with severe coronary artery occlusion, aiming for earlier heart attack detection. The technology targets clinical and acute care settings such as emergency departments and pre-hospital paramedic use.
Founders & leadership
AB
ATANDRA BURMANNamed on SEC filing
LM
LOU MALICENamed on SEC filing
Investors · 1
Reported raises · per SEC filings
Form D private placements$5.8M disclosed across 5 rounds · 2019–2025
▶$25KraisedDec 2025 · 3 investors · Other Health CareRule 506(b)
▶$25KraisedDec 2025 · 3 investors · Other Health Care
Rule 506(b)Officers, directors & promoters on the filing
- Atandra BurmanExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $25K
- Minimum investment
- $5K
- Proceeds to insiders
- $100K
- First sale
- Dec 2025
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$2.1MraisedNov 2025 · 37 investors · BiotechnologyRule 506(b)
▶$2.1MraisedNov 2025 · 37 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ATANDRA BURMANExecutive Officer, Director
- Offering amount
- $2.1M
- Amount sold
- $2.1M
- First sale
- Nov 2023
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.7MraisedDec 2023 · 43 investors · BiotechnologyRule 506(b)
▶$1.7MraisedDec 2023 · 43 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- LOU MALICEDirector
- ATANDRA BURMANExecutive Officer, Director
- Offering amount
- $2M
- Amount sold
- $1.7M
- First sale
- Jun 2022
- Incorporated
- Corporation, Delaware
- Federal exemptions
- 06b
▶$1.3MraisedJan 2022 · 14 investors · BiotechnologyRule 506(b)
▶$1.3MraisedJan 2022 · 14 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ATANDRA BURMANExecutive Officer, Director
- LOU MALICEDirector
- Offering amount
- $2M
- Amount sold
- $1.3M
- First sale
- Jul 2021
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
▶$610KraisedJun 2021 · 23 investors · BiotechnologyRule 506(b)
▶$610KraisedJun 2021 · 23 investors · Biotechnology
Rule 506(b)Officers, directors & promoters on the filing
- ATANDRA BURMANExecutive Officer, Director
- LOU MALICEDirector
- Offering amount
- $2M
- Amount sold
- $610K
- First sale
- Jan 2019
- Incorporated
- Corporation, Delaware, 2018
- Federal exemptions
- 06b
Source: SEC EDGAR Form D. Amounts as filed; amended filings shown once at their latest values.
Non-dilutive funding · 1 SBIR/STTR award
Federal grants — no equity taken| Agency | Phase | Year | Amount |
|---|---|---|---|
| National Science Foundation | Phase I | 2023 | $255.9K |
Source: SBIR.gov award data (U.S. Small Business Administration). SBIR/STTR awards are competitive federal R&D grants and contracts — non-dilutive capital alongside any venture rounds above.
Frequently asked questions
- What does RCE Technologies do?
- RCE Technologies develops a wrist-worn wearable (Infrasensor) that uses infrared sensors and machine learning to detect signals associated with severe coronary artery occlusion, aiming for earlier heart attack detection. The technology targets clinical and acute care settings such as emergency departments and pre-hospital paramedic use.
- Who are RCE Technologies's investors?
- RCE Technologies's investors include Atlanta Technology Angels.
- How much funding has RCE Technologies raised?
- RCE Technologies has disclosed $5.8M raised across 5 rounds.
- Where is RCE Technologies headquartered?
- RCE Technologies is headquartered in Carlsbad, US.